PGEN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 44.90%

Insider Buying (Last 12 Months): $186,326.81

Insider Selling (Last 12 Months): $0.00

Precigen Insider Trading History Chart

Precigen Share Price & Price History

^$0.76

▲ +0.0368 (5.07%)

As of 12/20/2024 06:51 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Precigen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2024	Jeffrey Thomas Perez	SVP	Buy	58,823	$0.85	$49,999.55	743,097
12/28/2023	Randal J. Kirk	Director	Buy	96,686	$1.41	$136,327.26	1,096,686
9/22/2023	Dean J Mitchell	Director	Buy	25,000	$1.41	$35,250.00	356,836
8/25/2023	Helen Sabzevari	CEO	Sell	76,969	$1.53	$117,762.57	1,560,004
8/24/2023	Donald P. Lehr	Insider	Sell	10,947	$1.64	$17,953.08	428,916
8/24/2023	Harry Thomasian, Jr.	CFO	Sell	9,045	$1.64	$14,833.80	161,051
8/24/2023	Jeffrey Thomas Perez	SVP	Sell	8,891	$1.64	$14,581.24	458,903
8/24/2023	Rutul R Shah	COO	Sell	5,388	$1.64	$8,836.32	133,474
8/18/2023	Helen Sabzevari	CEO	Sell	55,855	$1.66	$92,719.30	1,495,386
8/17/2023	Donald P. Lehr	Insider	Sell	10,762	$1.55	$16,681.10	418,153
8/17/2023	Harry Thomasian, Jr.	CFO	Sell	8,893	$1.55	$13,784.15	152,162
8/17/2023	Jeffrey Thomas Perez	SVP	Sell	8,741	$1.55	$13,548.55	448,916
8/17/2023	Rutul R Shah	COO	Sell	5,298	$1.55	$8,211.90	123,382
8/16/2023	Randal J. Kirk	Director	Buy	119,411	$1.51	$180,310.61	31,837,786
8/14/2023	Steven Frank	Director	Buy	400,000	$1.72	$688,000.00	882,358
8/11/2023	Helen Sabzevari	CEO	Sell	41,436	$1.44	$59,667.84	1,409,654
8/10/2023	Donald P. Lehr	Insider	Sell	11,026	$1.21	$13,341.46	407,205
8/10/2023	Harry Thomasian, Jr.	CFO	Sell	6,852	$1.21	$8,290.92	143,121
8/10/2023	Jeffrey Thomas Perez	SVP	Sell	8,956	$1.21	$10,836.76	438,779
8/10/2023	Rutul R Shah	COO	Sell	5,429	$1.21	$6,569.09	113,200
8/4/2023	Helen Sabzevari	CEO	Sell	52,870	$1.10	$58,157.00	1,309,503
8/3/2023	Donald P. Lehr	Insider	Sell	10,821	$1.20	$12,985.20	396,521
8/3/2023	Harry Thomasian, Jr.	CFO	Sell	6,724	$1.20	$8,068.80	132,039
8/3/2023	Jeffrey Thomas Perez	SVP	Sell	8,789	$1.20	$10,546.80	428,857
8/3/2023	Rutul R Shah	COO	Sell	5,328	$1.20	$6,393.60	103,149
1/27/2023	Helen Sabzevari	CEO	Buy	22,857	$1.75	$39,999.75	937,613
1/27/2023	Jeffrey Thomas Perez	SVP	Buy	28,571	$1.75	$49,999.25	381,012
1/27/2023	Randal J. Kirk	Director	Buy	11,428,571	$1.75	$19,999,999.25	31,129,164
1/27/2023	Rutul R Shah	COO	Buy	9,142	$1.75	$15,998.50	62,037
8/23/2022	Harry Thomasian, Jr.	CFO	Buy	24,500	$2.09	$51,205.00	56,390
8/11/2022	Jeffrey B Kindler	Director	Sell	50,000	$2.30	$115,000.00	214,411
5/17/2022	Donald P. Lehr	Insider	Sell	18,196	$1.28	$23,290.88	323,274
5/17/2022	Harry Thomasian, Jr.	CFO	Sell	2,719	$1.28	$3,480.32	31,890
5/17/2022	Jeffrey Thomas Perez	SVP	Sell	14,778	$1.28	$18,915.84	333,502
5/13/2022	Helen Sabzevari	CEO	Sell	177,968	$1.19	$211,781.92	897,091
1/5/2022	Donald P. Lehr	Insider	Sell	10,356	$3.59	$37,178.04
1/5/2022	Helen Sabzevari	CEO	Sell	6,960	$3.59	$24,986.40
1/5/2022	Jeffrey Thomas Perez	SVP	Sell	9,738	$3.59	$34,959.42
1/3/2022	Donald P. Lehr	Insider	Sell	5,315	$3.67	$19,506.05
1/3/2022	Helen Sabzevari	CEO	Sell	3,848	$3.67	$14,122.16
1/3/2022	Jeffrey Thomas Perez	SVP	Sell	5,022	$3.67	$18,430.74

Could This Tiny Device Help You Make an Extra $30k a Year?

From Brownstone Research | Ad

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

SEC Filings (Institutional Ownership Changes) for Precigen (NASDAQ:PGEN)

33.51% of Precigen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Precigen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Synovus Financial Corp	98,130	$93K	0.0%	+100.0%	0.034%
11/19/2024	Barclays PLC	189,353	$0.18M	0.0%	+190.4%	0.065%
11/16/2024	Geode Capital Management LLC	3,246,508	$3.08M	0.0%	+4.8%	1.284%
11/15/2024	Barclays PLC	189,353	$0.18M	0.0%	+190.4%	0.075%
11/15/2024	Jane Street Group LLC	65,082	$62K	0.0%	-47.6%	0.026%
11/15/2024	State Street Corp	2,872,064	$2.72M	0.0%	+1.0%	1.136%
11/15/2024	Stifel Financial Corp	32,200	$30K	0.0%	+94.9%	0.013%
11/15/2024	HighTower Advisors LLC	192,144	$0.18M	0.0%	+186.8%	0.076%
11/13/2024	FMR LLC	345,204	$0.33M	0.0%	+26.4%	0.137%
11/12/2024	Charles Schwab Investment Management Inc.	1,222,850	$1.16M	0.0%	+11.6%	0.484%
11/6/2024	Mill Creek Capital Advisors LLC	110,000	$0.10M	0.0%	N/A	0.044%
10/25/2024	Iridian Asset Management LLC CT	3,775,960	$3.58M	0.8%	+82.5%	1.494%
10/25/2024	China Universal Asset Management Co. Ltd.	55,337	$52K	0.0%	+86.6%	0.022%
10/21/2024	Traphagen Investment Advisors LLC	31,000	$29K	0.0%	N/A	0.012%
10/17/2024	LexAurum Advisors LLC	274,489	$0.26M	0.1%	+13.8%	0.109%
10/10/2024	Exchange Traded Concepts LLC	167,496	$0.16M	0.0%	+10.2%	0.066%
10/9/2024	Sanders Morris Harris LLC	363,182	$0.34M	0.1%	-35.1%	0.144%
10/3/2024	SG Americas Securities LLC	45,063	$43K	0.0%	+44.2%	0.018%
8/15/2024	The Manufacturers Life Insurance Company	56,998	$90K	0.0%	+40.7%	0.023%
8/15/2024	AQR Capital Management LLC	50,002	$79K	0.0%	+56.7%	0.020%
8/9/2024	Renaissance Technologies LLC	1,182,690	$1.87M	0.0%	+12.4%	0.469%
8/8/2024	Fore Capital LLC	206,811	$0.33M	0.2%	-32.6%	0.082%
8/7/2024	ClariVest Asset Management LLC	492,152	$0.78M	0.1%	+2.9%	0.195%
7/29/2024	Principal Financial Group Inc.	24,783	$39K	0.0%	-60.4%	0.010%
7/26/2024	Iridian Asset Management LLC CT	2,069,145	$3.27M	0.7%	-1.1%	0.820%
7/26/2024	Bank of New York Mellon Corp	421,788	$0.67M	0.0%	+4.8%	0.167%
7/12/2024	SG Americas Securities LLC	31,240	$49K	0.0%	-39.7%	0.012%
7/12/2024	Sanders Morris Harris LLC	559,500	$0.88M	0.1%	-20.6%	0.222%
5/29/2024	Opaleye Management Inc.	947,500	$1.37M	0.3%	-6.4%	0.375%
5/24/2024	Cetera Advisors LLC	252,795	$0.37M	0.0%	N/A	0.100%
5/14/2024	EntryPoint Capital LLC	21,479	$31K	0.0%	N/A	0.009%
5/10/2024	Vanguard Group Inc.	6,768,234	$9.81M	0.0%	+0.3%	2.719%
5/7/2024	Fore Capital LLC	306,791	$0.45M	0.3%	-14.0%	0.123%
5/7/2024	SG Americas Securities LLC	51,769	$75K	0.0%	-32.2%	0.021%
5/2/2024	Iridian Asset Management LLC CT	2,091,274	$3.03M	0.6%	+4.3%	0.840%
4/30/2024	Fortis Group Advisors LLC	18,966	$28K	0.0%	N/A	0.008%
4/29/2024	China Universal Asset Management Co. Ltd.	47,829	$69K	0.0%	+66.1%	0.019%
4/24/2024	Simplicity Wealth LLC	35,204	$51K	0.0%	N/A	0.014%
4/11/2024	Sanders Morris Harris LLC	705,000	$1.02M	0.2%	N/A	0.283%
4/10/2024	LexAurum Advisors LLC	89,166	$0.13M	0.0%	-8.8%	0.036%
3/5/2024	Fisher Asset Management LLC	21,800	$29K	0.0%	N/A	0.009%
2/20/2024	MSD Partners L.P.	355,000	$0.48M	0.0%	-63.0%	0.143%
2/15/2024	Opaleye Management Inc.	1,012,500	$1.36M	0.4%	+9.0%	0.407%
2/15/2024	Patient Capital Management LLC	15,983,700	$21.42M	1.1%	+16.2%	6.421%
2/12/2024	Chiron Capital Management LLC	24,050	$32K	0.0%	-56.9%	0.010%
2/8/2024	Panagora Asset Management Inc.	303,385	$0.41M	0.0%	N/A	0.122%
2/6/2024	Fisher Asset Management LLC	21,800	$29K	0.0%	N/A	0.009%
1/30/2024	Emfo LLC	519,475	$0.70M	0.6%	+22.2%	0.209%
1/29/2024	Simplicity Solutions LLC	34,245	$46K	0.0%	-23.9%	0.014%
1/26/2024	Iridian Asset Management LLC CT	2,004,934	$2.69M	0.5%	-3.5%	0.805%
1/25/2024	Bleakley Financial Group LLC	34,245	$46K	0.0%	-23.9%	0.014%
1/24/2024	China Universal Asset Management Co. Ltd.	28,788	$39K	0.0%	+338.8%	0.012%
1/12/2024	SG Americas Securities LLC	76,352	$0.10M	0.0%	+12.5%	0.031%
1/8/2024	Diversified Trust Co	29,126	$39K	0.0%	N/A	0.012%
1/5/2024	Exchange Traded Concepts LLC	94,091	$0.13M	0.0%	+34.0%	0.038%
11/14/2023	Caxton Associates LP	34,863	$50K	0.0%	-55.3%	0.014%
11/14/2023	Synovus Financial Corp	49,065	$70K	0.0%	-52.9%	0.020%
11/8/2023	State Board of Administration of Florida Retirement System	38,560	$55K	0.0%	N/A	0.015%
11/7/2023	Virtus ETF Advisers LLC	79,754	$0.11M	0.1%	-9.1%	0.031%
11/6/2023	Fore Capital LLC	426,791	$0.61M	0.3%	-12.9%	0.167%
11/4/2023	Magnolia Capital Advisors LLC	39,997	$57K	0.1%	N/A	0.016%
11/1/2023	Emfo LLC	425,000	$0.60M	0.6%	+136.1%	0.166%
10/30/2023	Iridian Asset Management LLC CT	2,078,220	$2.95M	0.6%	-37.7%	0.813%
10/24/2023	Bank of New York Mellon Corp	455,238	$0.65M	0.0%	+5.2%	0.178%
10/18/2023	Exchange Traded Concepts LLC	70,232	$100K	0.0%	-34.8%	0.027%
10/16/2023	LexAurum Advisors LLC	92,666	$0.13M	0.0%	-9.1%	0.036%
10/13/2023	SG Americas Securities LLC	67,874	$96K	0.0%	N/A	0.027%
10/13/2023	Sanders Morris Harris LLC	410,000	$0.58M	0.1%	+26.2%	0.160%
10/5/2023	Sanders Morris Harris LLC	410,000	$0.58M	0.2%	+26.2%	0.160%
9/21/2023	Barclays PLC	48,856	$55K	0.0%	-41.5%	0.019%
8/14/2023	Graham Capital Management L.P.	36,127	$42K	0.0%	N/A	0.014%
8/9/2023	Iridian Asset Management LLC CT	3,333,468	$3.83M	0.4%	-6.6%	1.305%
8/7/2023	Principal Financial Group Inc.	65,326	$75K	0.0%	+34.7%	0.026%
8/3/2023	Emfo LLC	180,000	$0.21M	0.2%	N/A	0.070%
8/3/2023	Los Angeles Capital Management LLC	213,294	$0.25M	0.0%	-50.7%	0.083%
7/24/2023	Allspring Global Investments Holdings LLC	52,272	$60K	0.0%	+1,092.3%	0.020%
7/20/2023	Exchange Traded Concepts LLC	107,685	$0.12M	0.0%	N/A	0.042%
7/18/2023	Allspring Global Investments Holdings LLC	52,272	$60K	0.0%	+1,092.3%	0.020%
7/13/2023	Cambridge Investment Research Advisors Inc.	75,534	$87K	0.0%	+12.9%	0.030%
7/11/2023	Sanders Morris Harris LLC	325,000	$0.37M	0.1%	+27.5%	0.127%
5/11/2023	Synovus Financial Corp	104,065	$0.11M	0.0%	+112.1%	0.041%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	154,489	$0.16M	0.0%	-72.4%	0.060%
5/9/2023	GMT Capital Corp	668,830	$0.71M	0.0%	N/A	0.262%
5/9/2023	Fore Capital LLC	490,000	$0.52M	0.3%	+366.7%	0.192%
5/8/2023	ClariVest Asset Management LLC	266,856	$0.28M	0.0%	N/A	0.104%
5/4/2023	Summit Trail Advisors LLC	104,529	$0.11M	0.0%	+144.3%	0.041%
5/4/2023	Los Angeles Capital Management LLC	432,736	$0.46M	0.0%	-3.0%	0.169%
4/28/2023	SG Americas Securities LLC	52,354	$55K	0.0%	+48.2%	0.020%
4/28/2023	Janney Montgomery Scott LLC	45,813	$49K	0.0%	-17.7%	0.018%
4/28/2023	Iridian Asset Management LLC CT	3,569,266	$3.78M	0.3%	+23.9%	1.397%
4/27/2023	Simplicity Solutions LLC	39,070	$41K	0.0%	N/A	0.015%
4/27/2023	Arizona State Retirement System	43,638	$46K	0.0%	+48.6%	0.017%
4/21/2023	Chiron Capital Management LLC	46,650	$49K	0.0%	-32.9%	0.018%
4/7/2023	Sanders Morris Harris LLC	255,000	$0.27M	0.1%	+183.3%	0.101%
3/23/2023	MetLife Investment Management LLC	17,466	$27K	0.0%	-67.8%	0.007%
2/14/2023	Patient Capital Management LLC	798,200	$1.21M	0.6%	+167.7%	0.318%
2/13/2023	American Financial Group Inc.	66,114	$100K	0.0%	N/A	0.026%
2/13/2023	The Manufacturers Life Insurance Company	43,234	$66K	0.0%	+96.8%	0.017%
2/13/2023	GSA Capital Partners LLP	247,945	$0.38M	0.0%	-31.4%	0.099%
2/10/2023	O Shaughnessy Asset Management LLC	17,719	$27K	0.0%	N/A	0.007%

Data available starting January 2016

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients; AdenoVerse immunotherapy, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and ActoBiotics for specific disease modification. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV-associated cancer; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis, as well as AG019, which is based on the ActoBiotics platform and in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Today's Range

Now: $0.76

$0.71

$0.77

50 Day Range

MA: $0.85

$0.67

$1.00

52 Week Range

Now: $0.76

$0.65

$1.93

Volume

1,823,299 shs

Average Volume

967,012 shs

Market Capitalization

$223.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.71

Who are the company insiders with the largest holdings of Precigen?: Precigen's top insider investors include:
Randal J Kirk (Director)
Helen Sabzevari (CEO)
Steven Frank (Director)
Jeffrey Thomas Perez (SVP)
Donald P Lehr (Insider)
Dean J Mitchell (Director)
Harry Jr Thomasian (CFO)
Rutul R Shah (COO)
Learn More about top insider investors at Precigen.
Who are the major institutional investors of Precigen?: Precigen's top institutional investors include:
Iridian Asset Management LLC CT — 1.49%
Geode Capital Management LLC — 1.28%
State Street Corp — 1.14%
Charles Schwab Investment Management Inc. — 0.48%
Sanders Morris Harris LLC — 0.14%
FMR LLC — 0.14%
Learn More about top institutional investors of Precigen stock.
Which major investors are selling Precigen stock?: During the last quarter, PGEN stock was sold by these institutional investors:
Sanders Morris Harris LLC
Jane Street Group LLC
Which major investors are buying Precigen stock?: Within the previous quarter, PGEN stock was bought by institutional investors including:
Iridian Asset Management LLC CT
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
HighTower Advisors LLC
Barclays PLC
Barclays PLC
Mill Creek Capital Advisors LLC
FMR LLC
Within the previous year, these company insiders have bought Precigen stock:
Randal J Kirk (Director)
Helen Sabzevari (CEO)
Steven Frank (Director)
Jeffrey Thomas Perez (SVP)
Donald P Lehr (Insider)
Dean J Mitchell (Director)
Learn More investors buying Precigen stock.

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol